Norman Noble, Inc., the world’s leading contract manufacturer of next-generation implants, has added dedicated capacity in its Process Development Centers (PDCs) to produce prototype iterations faster for medical device OEMs. The new capability, dubbed Rapid Development Effort (RDE), is currently available for:
· Laser Processing Services – Nitinol Stents, Transcatheter Heart Valves, Neuro Clot Pullers
· 5-axis Micro Milling & Turning – Polyaxial Screws, Bone Plates
Rapid Development Effort fills a critical need for medical device OEMs who, until now, had to choose between an ultra-fast 3D printed plastic prototype, or fully conforming machined part requiring longer lead times to produce. The new Rapid Development Effort prototyping service from Norman Noble bridges the gap between the two. Medical device OEMs can now complete functional or verification testing on metallic-based prototypes within a short lead time, enabling the engineer to move faster to the next design iteration.
Norman Noble Process Development Centers support customers with ultra-precision micromachining of medical devices from initial prototype, through all stages of FDA approval, to full-scale manufacturing.
The company’s process development centers are central to its customers’ ability to bring next-generation medtech devices to market quickly and cost-effectively, while meeting quality, delivery and regulatory requirements.